The Fort Worth Press - Who should get paid for nature's sequenced genes?

USD -
AED 3.672497
AFN 63.000127
ALL 83.045552
AMD 377.608336
ANG 1.790083
AOA 916.999582
ARS 1400.115202
AUD 1.437391
AWG 1.8025
AZN 1.698782
BAM 1.692703
BBD 2.017085
BDT 122.889314
BGN 1.709309
BHD 0.375272
BIF 2964.437482
BMD 1
BND 1.280822
BOB 6.920277
BRL 5.326897
BSD 1.001532
BTN 93.628346
BWP 13.656801
BYN 3.038457
BYR 19600
BZD 2.014228
CAD 1.373511
CDF 2274.999939
CHF 0.790045
CLF 0.023138
CLP 913.629897
CNY 6.886396
CNH 6.916875
COP 3696.54
CRC 467.791212
CUC 1
CUP 26.5
CVE 95.432004
CZK 21.264698
DJF 178.340531
DKK 6.480025
DOP 59.449729
DZD 131.454091
EGP 52.035801
ERN 15
ETB 157.836062
EUR 0.867199
FJD 2.21445
FKP 0.749521
GBP 0.752165
GEL 2.715018
GGP 0.749521
GHS 10.917148
GIP 0.749521
GMD 73.499323
GNF 8778.549977
GTQ 7.671603
GYD 209.529662
HKD 7.830705
HNL 26.509205
HRK 6.534203
HTG 131.388314
HUF 342.022986
IDR 16990.85
ILS 3.139701
IMP 0.749521
INR 93.948497
IQD 1311.97909
IRR 1315624.999818
ISK 124.719822
JEP 0.749521
JMD 157.346743
JOD 0.709014
JPY 159.524981
KES 129.250288
KGS 87.447897
KHR 4001.973291
KMF 426.999949
KPW 900.003974
KRW 1513.979862
KWD 0.30657
KYD 0.834581
KZT 481.491739
LAK 21506.092917
LBP 89692.06536
LKR 312.41778
LRD 183.27376
LSL 16.894603
LTL 2.95274
LVL 0.60489
LYD 6.411466
MAD 9.358386
MDL 17.440975
MGA 4176.061001
MKD 53.348104
MMK 2099.452431
MNT 3566.950214
MOP 8.084003
MRU 40.089837
MUR 46.570088
MVR 15.459624
MWK 1736.722073
MXN 17.992025
MYR 3.939499
MZN 63.897237
NAD 16.894749
NGN 1356.739806
NIO 36.852081
NOK 9.616303
NPR 149.804404
NZD 1.725615
OMR 0.382195
PAB 1.001519
PEN 3.46252
PGK 4.323066
PHP 60.376987
PKR 279.628351
PLN 3.713335
PYG 6541.287659
QAR 3.662273
RON 4.417101
RSD 101.650468
RUB 84.556145
RWF 1457.231632
SAR 3.754899
SBD 8.05166
SCR 13.74181
SDG 600.999794
SEK 9.395399
SGD 1.283745
SHP 0.750259
SLE 24.57502
SLL 20969.510825
SOS 572.35094
SRD 37.487497
STD 20697.981008
STN 21.204227
SVC 8.762971
SYP 110.564047
SZL 16.900787
THB 33.056504
TJS 9.619362
TMT 3.51
TND 2.95786
TOP 2.40776
TRY 44.32892
TTD 6.794814
TWD 32.133504
TZS 2600.260986
UAH 43.875212
UGX 3785.603628
UYU 40.356396
UZS 12210.172836
VES 454.69063
VND 26339
VUV 119.226095
WST 2.727792
XAF 567.726608
XAG 0.015794
XAU 0.000234
XCD 2.70255
XCG 1.80494
XDR 0.706079
XOF 567.716781
XPF 103.216984
YER 238.584438
ZAR 17.19515
ZMK 9001.198872
ZMW 19.554625
ZWL 321.999592
  • RIO

    -2.5000

    83.15

    -3.01%

  • RBGPF

    -13.5000

    69

    -19.57%

  • RELX

    -0.4600

    33.36

    -1.38%

  • NGG

    -3.5400

    81.99

    -4.32%

  • BTI

    -1.3500

    57.37

    -2.35%

  • CMSC

    -0.2000

    22.65

    -0.88%

  • GSK

    -0.5300

    51.84

    -1.02%

  • AZN

    -5.3300

    183.6

    -2.9%

  • VOD

    -0.0900

    14.33

    -0.63%

  • RYCEF

    -1.2600

    15.34

    -8.21%

  • CMSD

    -0.2420

    22.658

    -1.07%

  • BP

    -1.0800

    44.78

    -2.41%

  • BCE

    0.0600

    25.79

    +0.23%

  • BCC

    -1.5600

    68.3

    -2.28%

  • JRI

    -0.3900

    11.77

    -3.31%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Harrison--TFWP